Status: Not yet recruiting
Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye
Prospective, multicenter, randomized, vehicle-controlled, double-masked, study of CAM-101 topical ophthalmic solution compared to vehicle control followed by crossover to long-term follow-up open-label treatment with CAM-101 for one year.
Participants needed: 475
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Cambium Bio LimitedUpdated: Jun 12, 2026
Eligibility criteria
Male or female subjects who at the time of consent are 18 years of age or older,... [+10]
Any abnormal lid anatomy or blinking function in either eye. [+27]